Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.
United European Gastroenterol J
; 9(3): 398-406, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33203339
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Inflammatory Bowel Diseases
/
Antibodies, Monoclonal, Humanized
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
United European Gastroenterol J
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: